Recommended Global Immunology Conferences
Antibiotics Summit 2018
About Antibiotics Summit 2018
Conference series organizes over 500 International Conferences every year across USA, Europe & Asia with associated aid from 1000 more scientific societies and publishes over 600 Open Access Journals which contains over 3000 lionized personalities, reputed scientists as its editorial board members.
We are overwhelmed to announce and welcome you all to the commencement of our “Annual Congress on Antibiotics and Antimicrobial Resistance”(Antibiotics Summit 2018) on December 06-08, 2018 Amsterdam, Netherland under the theme of Antibiotics: Immunological Techniques and Antimicrobial Resistance.
In this Conference we invite eminent personalities from universities, clinical research institutions and diagnostic companies, business people oriented with the field of antibiotics to share their research involvements and views on all aspects of this rapidly growing field of antibiotics and thereby, providing a showcase of their latest techniques.
Over the years antibiotics have saved many lives by the process of how bacteria were killed using antibiotics. A new study reveals that penicillin and other antibiotics produce destructive molecules that fatally damage bacterial DNA through a long chain of cellular events. New targets involve some bacterial cell is able to save itself from antibiotic-induced DNA damage. Thus recent research is required to understand and solve this problem.
Why to attend?
Antibiotics Summit 2018 gives a platform to discuss and learn about the latest advancement in the field of Immunology and Antibiotics. As Antibiotic Resistance has become a topic of consideration and urgency of discovering new antibiotics due to growing antimicrobial resistance.
This conference is a gathering of researchers, academia, health professionals, hospitals, young researchers, drug manufacturers, Business Entrepreneurs, Faculties of related companies and associations. We are featuring many exciting academic programs including multiple panels, workshops, affinity group lunches, paper presentations, and scientific sessions by reputed personalities related to the field of antibiotics all over the world which makes our conference the best of other conferences.
International conference Highlights:
- All accepted abstracts for this Conference will be published in the respective International Journals
- Group Registration benefits
- Special awards for Speakers and Poster Presentations
- Keynote sessions by eminent and renowned researchers
- Meet eminent people from the field of Antibiotics Associations & Societies.
- International accredited certificates
- Special recognition for Young Researchers
Sessions and Tracks
Track 01: Antibiotics
Antibiotics are type of Antimicrobial drugs used in treatment and prevention of bacterial infections. Normally they are medicines that help stop infections caused by bacteria. Some infections such as ear and sinus infections, Dental Infections, Skin Infections, Whooping Cough, Bladder and Kidney Infections and even cancer etc. can be cured using antibiotics. Some are toxic to humans and animals also, even when given in therapeutic dosage.
|Introduction to Antibiotic Uses||Basic Principles of Prescribing Antibiotics|
|Mechanism of Action of Antibiotics||Antibiotics Related Microorganism|
Track 02: Application of Antibiotics
The choice of relevant antibiotics is presently based on individual patient’s need. A large number of bacterial diseases have been brought under control by using antibiotics. These include pneumonia, cholera, tuberculosis and leprosy. The antifungal antibiotic griseofulvin has controlled the debilitating fungal skin diseases such as ring worm. Antibiotics can be used in many other fields rather than a Antimicrobial agent. There are certain antibiotics which can be used in canning Industry or antibiotics such as penicillins, tetracyclines, erythromycins were very widely used in processing of animal feeds.
|Principle of Antibiotic Therapy||Administration of Antibiotics|
Track 03: Types of Antibiotics
Antibiotics belong to a class of antimicrobials, a larger group which also includes anti-virals, anti-fungal, and anti-parasitic drugs. The main classes of antibiotics are Beta-Lactams which again include Penicillins and cephalosporin, Macrolides, Fluoroquinolones, Tetracyclines, and Aminoglycosides.
Track 04: Antibiotic Resistance
Antibiotic resistance occurs when bacteria develop the ability to defeat the drugs designed to kill them. Antibiotic resistance can naturally evolve via natural selection through random mutation, but it could also be engineered by applying an evolutionary stress on a population. Overuse of broad-spectrum antibiotics, such as second- and third-generation cephalosporin, can develop resistance very easily. Bacteria have an ability to neutralize an antibiotic by changing it in a way that makes it harmless others have learned how to pump an antibiotic back outside of the bacteria. Some bacteria can change their outer structure so that the antibiotic cannot attach itself to the bacteria’s body.
|Emergence of Antibiotic resistance||Mechanism of Antibiotic Resistance|
|Bacterial Antibiotic Resistance||Preventing Drug Resistance|
Track 05: Mechanism: Antibiotics
Antibiotic action falls under main five mechanism
- Inhibition of Cell Wall Synthesis
- Inhibition of Protein Synthesis (Translation)
- Alteration of Cell Membranes
- Inhibition of Nucleic Acid Synthesis
- Antimetabolite Activity
Different antibiotics have different modes of action, owing to the nature of their structure and degree of affinity to certain target sites within bacterial cells.
|Broad Spectrum||Pharmacokinetics of Antibiotics|
|Nuclear Material||Pharmacodynamics of Antibiotics|
Track 06: Interaction of Antibiotics
The potentiation of toxic side effects of one drug by another is a common type of interaction. Alcohol can interact severely with antibiotic Antibiotics can also interact with birth Control pills greatly. There are two ways that antibiotics potentially can reduce the action of birth control pills. Birth control pills contain estrogens so some antibiotics cause the enzymes in the liver to increase the break-down of estrogens and thereby can decrease the levels of estrogens in the body and thus can reduce the effectiveness of the pills.
|Correlation with Obesity||Alcohol|
|Interaction with Birth Control Pills|
Track 07: Pediatric Antibiotics
Prescription of antibiotics in children is a scrupulous act. Side effects from antibiotics are a common reason that children go to the emergency room. The drugs can cause diarrhea or vomiting, and about 5 in 100 children have allergies to them. Some of these allergic reactions can be serious and life threatening. The repeat prescriptions at interval 0–2 days may be considered as overprescribing.
Track 08: Drug Discovery
The idea that the effect of a drug in the human body is mediated by specific interactions of the drug molecule with biological macromolecules, (proteins or nucleic acids in most cases) led scientists to the conclusion that individual chemicals are required for the biological activity of the drug. This made for the beginning of the modern era in pharmacology, as pure chemicals, instead of crude extracts of medicinal plants, became the standard drugs.
|Factors to Stimulate Drug Development||Ligand Binding Studies|
|Role of Computational Biology||Molecule Mediating Transport|
Track 09: Antibiotic Prophylaxis
Antibiotic prophylaxis is the use of antibiotics before surgery or a dental procedure to prevent a bacterial infection. Antimicrobial prophylaxis is commonly used by clinicians for the prevention of numerous infectious diseases, including herpes simplex infection, rheumatic fever, recurrent cellulitis, meningococcal disease, recurrent uncomplicated urinary tract infections in women etc. The choice of antibiotics should be made according to data on pharmacology, microbiology, clinical experience and economy. Drugs should be selected with a reasonable spectrum of activity against pathogens likely to be encountered.
|Prevention of Microbial Infection||Advantages of Long-Acting Antibiotics|
Track 10: Next Generation Approach
The increasing fear of drug-resistant superbugs is leading to a growing push for the next generation of antibiotics. The development of new antibiotics is crucial to controlling current and future infectious diseases caused by antibiotic-resistant bacteria. The discovery of a new antibiotic called teixobactin was announced by international team of researchers in 2017. The researchers now plan on studying the bacteria and decide what tools might be able to control its behavior to release its full antibiotic potential. An expected 5– 10% of all hospitalizations are perplex by a nosocomial disease with an expected cost of $4.5– 5.7 billion every year in the USA alone. More varieties of biological solution are yet to be discovered in this field.
|Bacterial Biofilms||Empiric Antibiotic Therapy|
|Oral Antibiotic Therapy||Combination Therapy|
|Combination Therapy||Molecular Epidemiology|
Track 11: Antibiotics Industrial Scope
Antibiotics can be used in non-medical industries. They are mainly used in animal husbandry, bee-keeping, fish farming and other forms of aquaculture, ethanol production, horticulture, antifouling paints, food preservation, and domestically.
|Antibiotics of Veterinary Importance||Antibiotics in Food Industry|
|Antibiotics in Aquaculture||Antibiotics in Agriculture|
Track 12: Oncology Antibiotics
Laboratory-produced drugs used to target and destroy cancerous cells. Therapeutic anticancer antibiotics have become an accepted treatment for certain types of cancer. These drugs bind specifically to primary and metastatic cancer cells to block cell growth, while limiting effects on surrounding healthy cells. Antibiotic medicines kill malignant cells by fragmenting the DNA in the cell nucleus and by oxidizing critical compounds the cells need.
For patients receiving chemotherapy, there is an increased risk of infection due to a low white blood cell count (neutropenia) caused by a toxic effect of chemotherapy on the bone marrow. Preventive antibiotic therapy before the development of fever prevents illness and death in people with a low white blood cell count after chemotherapy.
|Anticancer Antibiotics||Can Antibiotics Increase the Risk of Cancer?|
|Role of Antibiotics in Killing Cancer Stem Cells||Antibiotics in Breast Cancer Treatment|
|Antibiotics for Anti-Cancer Therapy(FDA-Approved)||Antibiotics in Acne Treatment|
|Antibiotics Against Lung Cancer Cells|
Track 13: Antibiotics Alternative
Certain microorganisms such as the cordial microscopic organisms that colonize the linings of the insides, upper respiratory tract, and lower urinary framework, withstanding the microorganisms, adding to safe protection and great absorption. Numerous alternatives to antibiotics are already being tested by researchers around the world. Two of these are the use of metals such as silver, zinc, and copper and the use of organic acids such as food acid that is used as a preservative in the food industry.
|Natural Foods||Resistance-Modifying Agents|
Track 14: Antibiotics and Public Heath
Antibiotics are strong medicines that treat bacterial infections. Common illnesses caused by bacteria are urinary tract infections, strep throat, and some pneumonia. Antibiotics can treat bacterial infections by killing the bacteria that causes them. Tetracycline are often used to treat acne and rosacea. Sulfonamides used to treat UTIs, bronchitis, eye and ear infections, pneumonia, and bacterial meningitis. Cephalosporin can be used to treat UTIs, ear and skin infections, respiratory infections, bacterial meningitis, and sepsis.
|Antibiotics for Diabetes||Inflammatory and Infectious Diseases|
|Antibiotics: In Pregnancy and Lactation||Anti-aging Antibiotics|
|Fever and Apparent Acute CNS Infection||Urinary Tract Infections|
|Water borne Diseases||Pulmonary Infections|
Track 15: Current Challenge and Market
At the current rate of emergence and spread of AMR, annual loss of life is expected to reach 10 million deaths by 2050 with an estimated economic cost of $100 trillion. The global antibiotic market is primarily driven by the development of novel approaches for new antibiotics for treating bacterial infections and a large number of clinical trials. Currently, Asia Pacific accounts for the leading share in the global antibiotic market. The region is likely to present exciting growth opportunities .The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.
|Systemic Intervention||Global Antibiotics Market|
|Intervention Against Antimicrobial Resistance||Antibiotics Market|
Track 16: Antimicrobial Resistance
Antimicrobial resistance happens when microorganisms (such as bacteria, fungi, viruses, and parasites) change when they are exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals, antimalarial, and anthelmintic). Without effective antimicrobials for prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, diabetes management and major surgery become very high risk. Antimicrobial resistance is a complex problem that affects all of society and is driven by many interconnected factors. Single, isolated interventions have limited impact. There have been increasing public calls for global collective action to address the threat, including a proposal for international treaty on antimicrobial resistance.
|Antimicrobial Resistance Causes||Genetics of Antimicrobial Resistance|
|How Bacteria Resist Pennicilin||Proteomics of Antimicrobial Resistance|
|Antibiotic and Antimicrobial Resistance Difference|
Track 17: Entrepreneurs Investment Meet
Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. Supportive government legislations, such as the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.
The demand gives a primary aspect for any product to flourish in market .This demand of antibiotic is increasing due to the rise in the incidence of infectious diseases across the globe over the forecast period, emerging infectious diseases, and the increasing antibiotics resistance in supply and demand of antibiotics.
Importance & scope of Antibiotics:
According to a new market report from Transparency Market Research, the global antibacterial drugs market was valued at $43.55 billion in 2012 and is expected to grow at a Compound Annual Growth Rate(CAGR) of 0.3% from 2013 to 2019, and estimated to reach a value of $45.09 billion after 2019. Moreover, the other antibiotics such as penicillin have 8%, tetracyclines 4%, erythromycin 7%, streptomycin 1% and chloramphenicol has 1 % market.
However, development of resistance, especially in case of bacterial infections is on the rise and renders the antibiotic or its entire class ineffective, thereby critically impacting the overall antibiotic market. This problem gave new ideas to researchers for development of more efficient antibiotics and study about them.
Because of antibiotic over usage, certain bacteria have become resistant to the most powerful antibiotics available today, this is called Antibiotic resistance. Common infections which are treated by antibiotics are Acne, Bronchitis, conjunctivitis, Urinary tract infection etc. Antibiotics show effect after 24-48 hours. If not the bacteria could be resistant to that antibiotic, or it was not a bacteria. Side effects of antibiotics include allergy, type 1 hypersentivity reactions, toxic effects and disbacteriosis. Mechanism of action of antibiotics includes inhibition of cell wall synthesis, disruption of cell membrane, inhibition of protein synthesis, inhibition of nucleic acid.
It is estimated that antimicrobial resistance (AMR) is directly responsible for 23 000 deaths annually in the United States and more than 25 000 in the European Union. A conservative estimate of the economic cost of bacterial resistance is $55 billion dollars annually in the United States alone.
Scope of antibiotics in future:
The efficacy of the world’s antibiotics is quickly decaying – the drugs we’re using to treat diseases are working less .But we are not likely to continue at this scale. The world is concerned about this problem and there are many governments organizations, research institutes, and concerned citizens working hard to avoid this scenario and antibiotic is a important aspect of our life.
It is expected that antibacterial usage will decrease slightly in developed countries as a result of an increasing pressure to combat antimicrobial resistance (AMR). Despite this, the antibacterial drug market is forecasted to grow from USD27.7 Billion in 2017 to USD35.6 Billion in 2022, at a compound annual growth rate (CAGR) of 3.97%.
List of Universities:
- University of Tokyo
- National University of Singapore (NUS)
- Kyoto University.
- University of Hong Kong (HKU)
- Peking University.
- Seoul National University (SNU)
- National Taiwan University (NTU)
- Osaka University.
- University of Vienna
- Vienna University of technology
- Johannes Kepler University Linz
- Karl-Franzens-Universität Graz
- KU Leuven
- Ghent University
- University of California
- Duke University
- Stanford University
- Columbia University
Why Amsterdam, Netherlands?
Amsterdam is intensely urbanized located in the province of North Holland in the west of the country Tourist’s attractions of Amsterdam are The Rijksmuseum, The Anne Frank Museum, The Van Gogh Museum, The West Church, Rembrandt House Museum, The Royal Palace, The Jewish Historical Museum, The Begijnhof, The Old Church and The Port of Amsterdam. Amsterdam is a city with more than 6,000 houses and buildings protected as monuments and dating from the 16th to the 20th century, Amsterdam boasts the largest historical inner city in Europe. Its best attraction in town is a canal cruise. It’s an excellent introduction to the city’s many sights.
Amsterdam has an ideal climate for a city trip throughout the year. Amsterdam’s well-known charming and easy-going atmosphere make it easy to have a tour. Amsterdam is in the Top 15 safest cities in the world. Amsterdam is currently one of the best European cities in which to locate an international business. It is ranked fifth in this category and is only surpassed by London, Paris, Frankfurt and Barcelona, The Port of Amsterdam is the fourth largest port in Europe.
Past Conference Report
Conference Series LLC Ltd hosted the “3rd World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2017) during July 31-August 01, 2017 at Hilton Garden Inn Milan North, Milan, Italy.
Antibiotics 2017 is specifically premeditated with a unifying axiom providing platform to widen the imminent scientific discoveries in the field of Antibiotics and Antibiotic Resistance and to deliver novel ideas besides incorporating better understanding of their role in Pharma, Drug Manufacturers, Business Management and Marketing. The scientific meeting has laid the path for the development and the validation of Antibiotics and Antibiotic Resistance under the theme of “The Future Of Antibiotics: Key Opportunities & Emerging Therapies”.
The conference invited Scientific Professionals, Researchers and Corporate Leaders from diverse disciplines emphasizing the areas of types & approaches for Antibiotic Treatment, The Emergence of Antimicrobial Resistance, Antibiotic Resistance: Opportunities and Challenges, Antibiotics for Emerging and Re-emerging Diseases, Antibiotic Prophylaxis etc.
Conference Series LLC Ltd is prerogative to thank the Organizing Committee, Editorial Board Members and Moderator – Dr. Siham M.Mahgoub, Alzahra Hospital Dubai, UAE, speaker participants, poster presenters and attendees for enormous support and participation in this grand venture.
The highlights of the meeting were the eponymous lectures, delivered by the following speakers:
Byungse Suh, Temple University School of Medicine, USA
Hartmut Derendorf, University of Florida, USA
Surbhi Malhotra Kumar, University of Antwerp, Belgium
Tadashi Shimamoto, Hiroshima University, Japan
Samir Kumar-Singh, University of Antwerp, Belgium
Siham M.Mahgoub, Alzahra Hospital Dubai
By the endless support of the Journal of Drug Metabolism & Toxicology, Advances in Pharmacoepidemiology & Drug Safety, Drug Designing: Open Access and Advances in Antibiotics & Antibodies. Conference Series LLC Ltd is pleased to announce our Annual Congress on Antibiotics and Antimicrobial Resistance on December 06-08, 2018 Amsterdam, Netherlands
Past Reports Gallery